Zobrazeno 1 - 10
of 16
pro vyhledávání: '"V. Yu. Kalashnikov"'
Autor:
A. A. Voznesenskaya, I. Z. Bondarenko, K. V. Melkozerov, R. S. Kosharnaya, A. S. Zakharov, M. Yu. Movsesyants, M. D. Kuklina, V. Yu. Kalashnikov
Publikováno v:
Сахарный диабет, Vol 25, Iss 5, Pp 514-521 (2022)
Diabetes mellitus (DM) type 1 accounts for up to 90% of all cases of diabetes among children, adolescents and young adults (10 % are represented by T2DM, MODY, etc.). DM is characterized not only by glucose metabolism disorder, but also by abnormal p
Externí odkaz:
https://doaj.org/article/dbb30ca3a75e445a8e6a9871539e92a1
Autor:
I. I. Dedov, G. A. Frank, N. G. Mokrisheva, M. V. Shestakova, G. A. Melnichenko, G. V. Zayratyants, P. G. Malkov, A. Yu. Abrosimov, O. K. Vikulova, G. R. Galstyan, A. Yu. Mayorov, E. A. Troshina, V. Yu. Kalashnikov
Publikováno v:
Сахарный диабет, Vol 24, Iss 3, Pp 300-309 (2021)
Coding of the causes of death of patients with diabetes mellitus (DM) in the Russian Federation is one of the long-discussed problems, due to the comorbidity of diabetes and cardiovascular diseases (CVD) and a number of contradictions in the key regu
Externí odkaz:
https://doaj.org/article/12a64e8a07f54670bfa3329fda431331
Autor:
A. Yu. Lebedeva, O. M. Koteshkova, O. N. Dzhioeva, S. R. Gilyarevsky, T. M. Uskach, M. S. Novikova, Ya. A. Orlova, V. Yu. Kalashnikov, D. V. Privalov, N. A. Ananicheva, M. Yu. Gilyarov, A. D. Erlikh
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 1, Pp 165-168 (2021)
The results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some proposals and recommendations for further study of the cardiovascular and renal effects of emp
Externí odkaz:
https://doaj.org/article/8642d167fac5420cbea6c65fee3a0b3e
Autor:
A S Zakharov, M S Michurova, S A Terekhin, V Yu Kalashnikov, O M Smirnova, M V Shestakova, I I Dedov
Publikováno v:
Терапевтический архив, Vol 91, Iss 12, Pp 41-46 (2019)
Type 2 diabetes mellitus (T2DM) is a serious medical and social problem leading to early disability of patients and high mortality from cardiovascular complications. The development of cardiovascular events is associated not only with the degree of c
Externí odkaz:
https://doaj.org/article/a65b6fadb4204f87b236524a6b327055
Autor:
G. R. Galstyan, A. S. Galyavich, E. N. Grineva, V. S. Gurevich, M. V. Ezhov, V. Yu. Kalashnikov, Yu. A. Karpov, A. M. Mkrtumyan, S. V. Nedogoda, O. G. Smolenskaya, E. V. Shlyakhto, A. N. Yakovlev
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 12, Pp 103-106 (2018)
Externí odkaz:
https://doaj.org/article/330d5f7ae5ed467ebb259d668c01782d
Autor:
I. I. Dedov, M. V. Shestakova, A. Yu. Mayorov, T. V. Nikonova, G. R. Galstyan, M. Sh. Shamkhalova, O. K. Vikulova, V. Yu. Kalashnikov, N. G. Mokrysheva
Publikováno v:
Сахарный диабет, Vol 24, Iss 1, Pp 74-75 (2021)
Externí odkaz:
https://doaj.org/article/3764346bf4cf47a88b094aff76079ded
Autor:
M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 12, Iss 2, Pp 186-190 (2016)
The interdisciplinary interim experts’ council on March 3, 2016 in Moscow have considered the EMPA-REG OUTCOME trial results and suggested a number of propositions and recommendations on further empagliflozin’s cardiovascular effects investigatio
Externí odkaz:
https://doaj.org/article/d608ec07d496465b915f7574e313a79b
Publikováno v:
Терапевтический архив, Vol 87, Iss 10, Pp 19-25 (2015)
Aim. To determine the levels of growth factors and glycation end products in patients with different forms of coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM). Subjects and methods. A total of 134 patients with CHD and T2DM, including
Externí odkaz:
https://doaj.org/article/f5513ace006a46b79b848d9a4c069dd1
Publikováno v:
Терапевтический архив, Vol 87, Iss 10, Pp 11-18 (2015)
Aim. To study the nature and severity of heart rate variability (HRV) and heart rate turbulence (HRT) abnormalities in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM) and to assess the prevalence of cardiovascular auto
Externí odkaz:
https://doaj.org/article/970f1d16ae2a4bd7a434d3f75c9318b7
Autor:
N A Ananicheva, M. Yu. Gilyarov, T. M. Uskach, M. S. Novikova, A. Yu. Lebedeva, A. D. Erlikh, Ya A Orlova, S. R. Gilyarevsky, V. Yu. Kalashnikov, O. N. Dzhioeva, D. V. Privalov, O. M. Koteshkova
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 17, Iss 1, Pp 165-168 (2021)
The results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some proposals and recommendations for further study of the cardiovascular and renal effects of emp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb6fea71a9cbe00da28669508d4b70d6
https://doi.org/10.20996/1819-6446-2021-01-03
https://doi.org/10.20996/1819-6446-2021-01-03